ALLO - Allogene Therapeutics EPS beats by $0.21 beats on revenue May, 05 2021 04:26 PM Allogene Therapeutics Inc. Allogene Therapeutics (ALLO): Q1 GAAP EPS of -$0.25 beats by $0.21.Revenue of $38.35M beats by $26.42M.Press Release For further details see: Allogene Therapeutics EPS beats by $0.21, beats on revenue